Retrieve available abstracts of 179 articles: HTML format
Single Articles
June 2025
HASSAN IN, Ashraf H, Hasan A Sudan conflict: impact on interrupted care after acute myocardial infarction.
Eur Heart J. 2025 Jun 12:ehaf313. doi: 10.1093. PubMed
ARENAS-MONTES J, Alcala-Diaz JF, Garcia-Fernandez H, Gutierrez-Mariscal FM, et al A microbiota pattern associated with cardiovascular events in secondary
prevention: the CORDIOPREV study.
Eur Heart J. 2025;46:2104-2115. PubMedAbstract available
RYAN M, Petrie MC, Kontopantelis E, Dodd M, et al Medical therapy and outcomes in REVIVED-BCIS2 and STICHES: an individual patient
data analysis.
Eur Heart J. 2025;46:2052-2062. PubMedAbstract available
MAHENDIRAN T, Bouisset F, Tonino P, Pijls NHJ, et al Titanium-nitride-oxide-coated vs. drug-eluting stents in acute coronary
syndromes: an individual patient data meta-analysis.
Eur Heart J. 2025;46:2092-2100. PubMedAbstract available
May 2025
PROCOPI N, Zeitouni M, Kerneis M, Cayla G, et al Beta-blocker interruption effects on blood pressure and heart rate after
myocardial infarction: the AbetaYSS trial.
Eur Heart J. 2025 May 22:ehaf170. doi: 10.1093. PubMedAbstract available
CLELAND JGF Staring into the AbetaYSS: how many pills and for how long after myocardial
infarction?
Eur Heart J. 2025 May 22:ehaf226. doi: 10.1093. PubMed
COYLE M, McEvoy JW Age-specific troponin thresholds: considerations for the fifth universal
definition of myocardial infarction.
Eur Heart J. 2025 May 9:ehaf308. doi: 10.1093. PubMed
WANG J, Verkerk AO, Wilders R, Zhang Y, et al SCN10A-short gene therapy to restore conduction and protect against malignant
cardiac arrhythmias.
Eur Heart J. 2025;46:1747-1762. PubMedAbstract available
PERRY CGR, Sweeney G Targeting mitochondrial fission for the treatment of myocardial infarction.
Eur Heart J. 2025 May 6:ehaf296. doi: 10.1093. PubMed
OIKONOMOU G, Cheng K, Mohiaddin RH CMR: a gatekeeper before ICA in a stable non ST-elevation myocardial infarction
patient with severely impaired LV function.
Eur Heart J. 2025 May 6:ehaf300. doi: 10.1093. PubMed
FEZZI S, Giacoppo D, Fahrni G, Latib A, et al Individual patient data meta-analysis of paclitaxel-coated balloons vs.
drug-eluting stents for small-vessel coronary artery disease: the ANDROMEDA
study.
Eur Heart J. 2025;46:1586-1599. PubMedAbstract available
WEYRICH M, Zewinger S, Sarakpi T, Rasper T, et al Mosaic loss of Y chromosome and mortality after coronary angiography.
Eur Heart J. 2025;46:1603-1616. PubMedAbstract available
ZHANG Q, Li H, Zhuang T, Xu L, et al CCN5 suppresses injury-induced vascular restenosis by inhibiting smooth muscle
cell proliferation and facilitating endothelial repair via thymosin beta4 and Cd9
pathway.
Eur Heart J. 2025;46:1645-1658. PubMedAbstract available
April 2025
CREA F Focus on heart failure: sex-related differences, new light shed on SGLT2i
mechanism of action, and heart failure after myocardial infarction.
Eur Heart J. 2025;46:1457-1461. PubMed
MOLLER JE, Thiele H, Morrow D, Kjaergaard J, et al Mechanical circulatory support: when, how, and for whom.
Eur Heart J. 2025;46:1480-1492. PubMedAbstract available
CHEN J, Zhao J, Fu S Addressing sample overlap and meta-analysis imbalances in Mendelian
randomization: a critical appraisal of protein targets for myocardial infarction.
Eur Heart J. 2025 Apr 18:ehaf186. doi: 10.1093. PubMed
TITOVA OE, Yuan S, Larsson SC Applying Mendelian randomization to study the relationship between circulating
proteins and myocardial infarction.
Eur Heart J. 2025 Apr 18:ehaf187. doi: 10.1093. PubMed
BOUGHANEM H, Herrero-Cervera A, Soehnlein O SiglecF+ neutrophils link periodontitis to impaired post-myocardial infarction
repair.
Eur Heart J. 2025 Apr 8:ehaf165. doi: 10.1093. PubMed
March 2025
CHIU IM, Ouyang D Acute myocardial infarction diagnosis: impact of artificial intelligence-powered
ECG interpretation.
Eur Heart J. 2025 Mar 25:ehaf142. doi: 10.1093. PubMed
SOUZA ACDAH, Troschel AS, Marquardt JP, Hadzic I, et al Skeletal muscle adiposity, coronary microvascular dysfunction, and adverse
cardiovascular outcomes.
Eur Heart J. 2025;46:1112-1123. PubMedAbstract available
XU Y, Feng T, Huang Y Gender-specific associations and circulating proteins in myocardial infarction:
potential causal relationships.
Eur Heart J. 2025 Mar 7:ehaf111. doi: 10.1093. PubMed
TITOVA OE, Yuan S, Byberg L, Baron JA, et al Circulating proteins and incident myocardial infarction: appraising sex-specific
differences and causality.
Eur Heart J. 2025 Mar 7:ehaf113. doi: 10.1093. PubMed
BOUZID Z, Sejdic E, Martin-Gill C, Faramand Z, et al Electrocardiogram-based machine learning for risk stratification of patients with
suspected acute coronary syndrome.
Eur Heart J. 2025;46:943-954. PubMedAbstract available
CLAESSEN G, Eijsvogels TMH, Albert CM, Baggish AL, et al Coronary atherosclerosis in athletes: emerging concepts and preventive
strategies.
Eur Heart J. 2025;46:890-903. PubMedAbstract available
CALAFIORE AM, Prapas S, Gaudino M Arterial conduits for coronary bypass grafting: the set-point concept.
Eur Heart J. 2025;46:922-925. PubMedAbstract available
DANG QM, Psaltis PJ, Burgess S, Chandrasekhar J, et al The Australian-New Zealand spontaneous coronary artery dissection cohort study:
predictors of major adverse cardiovascular events and recurrence.
Eur Heart J. 2025 Mar 7:ehaf097. doi: 10.1093. PubMedAbstract available
February 2025
LEE MS, Shin TG, Lee Y, Kim DH, et al Artificial intelligence applied to electrocardiogram to rule out acute myocardial
infarction: the ROMIAE multicentre study.
Eur Heart J. 2025 Feb 24:ehaf004. doi: 10.1093. PubMedAbstract available
CHEN G, Gan J, Wu F, Zhou Z, et al Scpep1 inhibition attenuates myocardial infarction-induced dysfunction by
improving mitochondrial bioenergetics.
Eur Heart J. 2025 Feb 11:ehaf032. doi: 10.1093. PubMedAbstract available
SQUIRE IB, Sze S Prognosis following acute myocardial infarction.
Eur Heart J. 2025 Feb 10:ehaf056. doi: 10.1093. PubMed
ROMAN M, Miksza J, Lai FY, Sze S, et al Revascularization in frail patients with acute coronary syndromes: a
retrospective longitudinal study.
Eur Heart J. 2025;46:535-547. PubMedAbstract available
CREA F Focus on the extreme of the spectrum: myocardial infarction with no obstructive
coronary arteries and ischaemic cardiomyopathy.
Eur Heart J. 2025;46:399-403. PubMed
RASMUSSEN LD, Schmidt SE, Knuuti J, Vrints C, et al Clinical risk prediction, coronary computed tomography angiography, and
cardiovascular events in new-onset chest pain: the PROMISE and SCOT-HEART trials.
Eur Heart J. 2025;46:473-483. PubMedAbstract available
RASMUSSEN LD, Westra J, Karim SR, Dahl JN, et al Microvascular resistance reserve: impact on health status and myocardial
perfusion after revascularization in chronic coronary syndrome.
Eur Heart J. 2025;46:424-435. PubMedAbstract available
January 2025
BUTLER J, Hammonds K, Talha KM, Alhamdow A, et al Incident heart failure and recurrent coronary events following acute myocardial
infarction.
Eur Heart J. 2025 Jan 28:ehae885. doi: 10.1093. PubMedAbstract available
PEDICINO D, Volpe M Weekly Journal Scan: A CLEAR message questions the routine use of spironolactone
in acute myocardial infarction.
Eur Heart J. 2025 Jan 21:ehae936. doi: 10.1093. PubMed
REEH J, Afzal S, Wulff AB, Nordestgaard BG, et al Ages at coronary heart disease and death in familial hypercholesterolaemia: a
Danish nationwide study spanning 44 years.
Eur Heart J. 2025 Jan 17:ehae912. doi: 10.1093. PubMedAbstract available
LIUZZO G, Patrono C Weekly Journal Scan: no CLEAR evidence of cardiovascular benefits of colchicine
after acute myocardial infarction.
Eur Heart J. 2025 Jan 9:ehae897. doi: 10.1093. PubMed
WILKINSON C, Bhatty A, Batra G, Aktaa S, et al Definitions of clinical study outcome measures for cardiovascular diseases: the
European Unified Registries for Heart Care Evaluation and Randomized Trials
(EuroHeart).
Eur Heart J. 2025;46:190-214. PubMedAbstract available
BJERKING LH, Skak-Hansen KW, Heitmann M, Hove JD, et al Acoustic-based rule-out of stable coronary artery disease: the FILTER-SCAD trial.
Eur Heart J. 2025;46:117-128. PubMedAbstract available
WENZL FA, Wang P, Arrigo M, Parenica J, et al Proenkephalin improves cardio-renal risk prediction in acute coronary syndromes:
the KID-ACS score.
Eur Heart J. 2025;46:38-54. PubMedAbstract available
December 2024
ZHANG Y, Yu S, Chen Z, Liu H, et al Gestational diabetes and future cardiovascular diseases: associations by
sex-specific genetic data.
Eur Heart J. 2024;45:5156-5167. PubMedAbstract available
PEDICINO D, Volpe M Weekly Journal Scan: The jury is still out on beta-blockers following acute
myocardial infarction with preserved ejection fraction after the ABYSS trial.
Eur Heart J. 2024 Dec 14:ehae858. doi: 10.1093. PubMed
CHAPMAN AR, Taggart C, Boeddinghaus J, Mills NL, et al Type 2 myocardial infarction: challenges in diagnosis and treatment.
Eur Heart J. 2024 Dec 10:ehae803. doi: 10.1093. PubMedAbstract available
November 2024
BACK M, Hofmann R Myocardial infarction and low ambient temperature: does presence or absence of
stenoses make a difference?
Eur Heart J. 2024 Nov 28:ehae820. doi: 10.1093. PubMed
AI L, de Freitas Germano J, Huang C, Aniag M, et al Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling
after myocardial infarction: role of PR-364.
Eur Heart J. 2024 Nov 27:ehae782. doi: 10.1093. PubMedAbstract available
OMEROVIC E, Ramunddal T, Petursson P, Angeras O, et al Percutaneous vs. surgical revascularization of non-ST-segment elevation
myocardial infarction with multivessel disease: the SWEDEHEART registry.
Eur Heart J. 2024 Nov 27:ehae700. doi: 10.1093. PubMedAbstract available
NARAYANAN S, Vuckovic S, Bergman O, Wirka R, et al Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and
with clinical and genetic data improves risk stratification.
Eur Heart J. 2024 Nov 18:ehae768. doi: 10.1093. PubMedAbstract available
BENDRISS E, Pasqueron J, Bardon J Coronary air embolism causing myocardial infarction following a blunt chest
trauma.
Eur Heart J. 2024 Nov 14:ehae771. doi: 10.1093. PubMed
WANG Y, Zeller M, Auffret V, Georgiopoulos G, et al Sex-specific prediction of cardiogenic shock after acute coronary syndromes: the
SEX-SHOCK score.
Eur Heart J. 2024;45:4564-4578. PubMedAbstract available
ZURIAGA MA, Yu Z, Matesanz N, Truong B, et al Colchicine prevents accelerated atherosclerosis in TET2-mutant clonal
haematopoiesis.
Eur Heart J. 2024;45:4601-4615. PubMedAbstract available
LANDMESSER U, Ali ZA, Maehara A, Matsumura M, et al Optical coherence tomography predictors of clinical outcomes after stent
implantation: the ILUMIEN IV trial.
Eur Heart J. 2024;45:4630-4643. PubMedAbstract available
October 2024
BLOOM JE, Vogrin S, Reid CM, Ajani AE, et al Coronary artery bypass grafting vs. percutaneous coronary intervention in severe
ischaemic cardiomyopathy: long-term survival.
Eur Heart J. 2024 Oct 29:ehae672. doi: 10.1093. PubMedAbstract available
HUANG J, He Q, Jiang Y, Wong JMJ, et al Low ambient temperature and incident myocardial infarction with or without
obstructive coronary arteries: a Chinese nationwide study.
Eur Heart J. 2024 Oct 28:ehae711. doi: 10.1093. PubMedAbstract available
KANG D, Choi KH, Kim H, Park H, et al Prognosis after switching to electronic cigarettes following percutaneous
coronary intervention: a Korean nationwide study.
Eur Heart J. 2024 Oct 21:ehae705. doi: 10.1093. PubMedAbstract available
KARAKASIS P, Pamporis K, Siontis KC, Theofilis P, et al Major clinical outcomes in symptomatic vs. asymptomatic atrial fibrillation: a
meta-analysis.
Eur Heart J. 2024 Oct 21:ehae694. doi: 10.1093. PubMedAbstract available
CHARTON J, Bouteiller X, Gandjbakhch E, Waintraub X, et al Overdrive pacing for ventricular fibrillation storm after myocardial infarction.
Eur Heart J. 2024 Oct 18:ehae698. doi: 10.1093. PubMed
LIUZZO G, Patrono C Weekly Journal Scan: Do older patients with non-ST-segment elevation myocardial
infarction receive any benefit from a routine invasive strategy?
Eur Heart J. 2024 Oct 18:ehae684. doi: 10.1093. PubMed
RAJAKULASINGAM R, Ferreira PF, Scott AD, Khalique Z, et al Characterization of dynamic changes in cardiac microstructure after reperfused
ST-elevation myocardial infarction by biphasic diffusion tensor cardiovascular
magnetic resonance.
Eur Heart J. 2024 Oct 15:ehae667. doi: 10.1093. PubMedAbstract available
CREA F Focus on ischaemic heart disease: secondary prevention, cardiogenic shock, and
novel therapeutic targets.
Eur Heart J. 2024;45:4141-4144. PubMed
TITOVA OE, Yuan S, Byberg L, Baron JA, et al Plasma proteome and incident myocardial infarction: sex-specific differences.
Eur Heart J. 2024 Oct 14:ehae658. doi: 10.1093. PubMedAbstract available
BARTON AK, Lau ES, Gulati M Steps towards curing Yentl syndrome: appraising sex differences in circulating
proteins and incident myocardial infarction.
Eur Heart J. 2024 Oct 14:ehae657. doi: 10.1093. PubMed
DESCH S, Zeymer U, Akin I, Behnes M, et al Routine extracorporeal life support in infarct-related cardiogenic shock: 1-year
results of the ECLS-SHOCK trial.
Eur Heart J. 2024;45:4200-4203. PubMed
WEINTRAUB WS, Boden WE Achieving successful prevention of coronary artery disease: a worldwide call to
action.
Eur Heart J. 2024;45:4197-4199. PubMed
LUSEBRINK E, Binzenhofer L, Thiele H The DanGer Shock trial: a new dawn but much to uncover.
Eur Heart J. 2024;45:4181-4183. PubMed
LUSCHER TF, Thiele H Cardiogenic shock: do we need a paradigm shift?
Eur Heart J. 2024;45:4178-4180. PubMed
Correction to: Great debate: myocardial infarction after cardiac surgery must be
redefined.
Eur Heart J. 2024 Oct 11:ehae734. doi: 10.1093. PubMed
AJUFO EC, Tedrow UB Refining the stratification of sudden cardiac death risk after myocardial
infarction-beyond ejection fraction.
Eur Heart J. 2024 Oct 8:ehae272. doi: 10.1093. PubMed
PEEK N, Hindricks G, Akbarov A, Tijssen JGP, et al Sudden cardiac death after myocardial infarction: individual participant data
from pooled cohorts.
Eur Heart J. 2024 Oct 8:ehae326. doi: 10.1093. PubMedAbstract available
SHIMADA T, Fujisawa N, Otsuka K Intracoronary polarimetric signatures of exercise-induced vasospastic angina.
Eur Heart J. 2024;45:3894. PubMed
September 2024
XU Y, Li H, Santosa A, Wettermark B, et al Cardiovascular events following coronavirus disease 2019 vaccination in adults: a
nationwide Swedish study.
Eur Heart J. 2024 Sep 30:ehae639. doi: 10.1093. PubMedAbstract available
CREA F New Guidelines and a focus on ischaemic heart disease, atrial fibrillation,
innovative treatments of channelopathies.
Eur Heart J. 2024;45:3299-3302. PubMed
BAIREY MERZ CN Vulnerable plaque and major adverse cardiovascular events: anatomy of a failure.
Eur Heart J. 2024;45:3748-3750. PubMed
BODEN WE, De Caterina R, Kaski JC, Bairey Merz N, et al Myocardial ischaemic syndromes: a new nomenclature to harmonize evolving
international clinical practice guidelines.
Eur Heart J. 2024;45:3701-3706. PubMedAbstract available
VRINTS C, Andreotti F, Koskinas KC, Rossello X, et al 2024 ESC Guidelines for the management of chronic coronary syndromes.
Eur Heart J. 2024;45:3415-3537. PubMed
NURMOHAMED NS, Min JK, Anthopolos R, Reynolds HR, et al Atherosclerosis quantification and cardiovascular risk: the ISCHEMIA trial.
Eur Heart J. 2024;45:3735-3747. PubMedAbstract available
VERGALLO R, Liuzzo G Weekly Journal Scan: The prognostic value of coronary inflammation in patients
with non-obstructive coronary artery disease.
Eur Heart J. 2024;45:3311-3313. PubMed
PEDICINO D, Volpe M Weekly Journal Scan: increased incidence of acute myocardial infarction in
patients with laboratory-confirmed influenza infection.
Eur Heart J. 2024 Sep 25:ehae569. doi: 10.1093. PubMed
ECHIVARD M, Sellal JM, Ziliox C, Marijon E, et al Prognostic value of ventricular arrhythmia in early post-infarction left
ventricular dysfunction: the French nationwide WICD-MI study.
Eur Heart J. 2024 Sep 20:ehae575. doi: 10.1093. PubMedAbstract available
GAUDINO M, Jaffe AS, Milojevic M, Sandoval Y, et al Great debate: myocardial infarction after cardiac surgery must be redefined.
Eur Heart J. 2024 Sep 16:ehae416. doi: 10.1093. PubMed
BADIMON L, Kiss A, Podesser BK Spleen in action for cardioprotection.
Eur Heart J. 2024;45:3178-3180. PubMed
NISHI T, Kume T, Saito Y, Kato K, et al Intraplaque haemorrhage, coronary spasm, and resuscitated cardiac arrest in
patients with non-obstructive coronary artery disease.
Eur Heart J. 2024;45:3181-3183. PubMed
LIUZZO G, Patrono C Weekly Journal Scan: a penULTIMATE frontier for optimal antiplatelet therapy
after drug-eluting stenting in acute coronary syndromes?
Eur Heart J. 2024;45:3108-3110. PubMed
LIEDER HR, Paket U, Skyschally A, Rink AD, et al Vago-splenic signal transduction of cardioprotection in humans.
Eur Heart J. 2024;45:3164-3177. PubMedAbstract available
GIBSON CM, Duffy D, Bahit MC, Chi G, et al Apolipoprotein A-I Infusions and Cardiovascular Outcomes in Acute Myocardial
Infarction According to Baseline LDL-Cholesterol Levels: The AEGIS-II Trial.
Eur Heart J. 2024 Sep 2:ehae614. doi: 10.1093. PubMedAbstract available
HAVERS-BORGERSEN E, Hartwell D, Ekelund C, Butt JH, et al Endometriosis and Long-Term Cardiovascular Risk: A Nationwide Danish study.
Eur Heart J. 2024 Sep 2:ehae563. doi: 10.1093. PubMedAbstract available
SCHNABEL RB, Benezet-Mazuecos J, Becher N, McIntyre WF, et al Anticoagulation in device-detected atrial fibrillation with or without vascular
disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trials.
Eur Heart J. 2024 Sep 2:ehae596. doi: 10.1093. PubMedAbstract available
TANIWAKI M, Haner JD, Kakizaki R, Ohno Y, et al Long-term effect of biodegradable vs durable polymer everolimus-eluting stents on
neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT
trial.
Eur Heart J. 2024 Sep 1:ehae589. doi: 10.1093. PubMedAbstract available
EITEL I, Saraei R, Jurczyk D, Fach A, et al Glycoprotein IIb/IIIa Inhibitors in Acute Myocardial Infarction and Angiographic
Microvascular Obstruction: The REVERSE-FLOW Trial.
Eur Heart J. 2024 Sep 1:ehae587. doi: 10.1093. PubMedAbstract available
SCHUBERT J, Leosdottir M, Lindahl B, Westerberg J, et al Intensive early and sustained lowering of non-high-density lipoprotein
cholesterol after myocardial infarction and prognosis: the SWEDEHEART registry.
Eur Heart J. 2024 Sep 1:ehae576. doi: 10.1093. PubMedAbstract available
VAN DEN BROEK WWA, Ten Berg JM The puzzle of antiplatelet therapy in ACS: ticagrelor monotherapy is another
missing piece.
Eur Heart J. 2024;45:3057-3059. PubMed
PRENDERGAST BD, Patterson T, Redwood S Acute coronary occlusion during valve-in-valve TAVI-a shortcut to successful
prevention.
Eur Heart J. 2024;45:3042-3044. PubMed
August 2024
ONDRACEK AS, Afonyushkin T, Aszlan A, Taqi S, et al Malondialdehyde-specific natural IgM inhibit NETosis triggered by culprit
site-derived extracellular vesicles from myocardial infarction patients.
Eur Heart J. 2024 Aug 31:ehae584. doi: 10.1093. PubMed
GERHARDT T, Landmesser U Malondialdehyde-specific natural IgM inhibit NETosis triggered by coronary
extracellular vesicles of myocardial infarction patients.
Eur Heart J. 2024 Aug 31:ehae554. doi: 10.1093. PubMed
WATANABE H, Natsuaki M, Morimoto T, Yamamoto K, et al Aspirin versus Clopidogrel Monotherapy After Percutaneous Coronary Intervention:
1-Year Follow-up of the STOPDAPT-3 Trial.
Eur Heart J. 2024 Aug 31:ehae617. doi: 10.1093. PubMedAbstract available
Correction to: Bleeding risk prediction after acute myocardial
infarction-integrating cancer data: the updated PRECISE-DAPT cancer score.
Eur Heart J. 2024 Aug 30:ehae581. doi: 10.1093. PubMed
MCEVOY JW, Jennings C, Kotseva K, De Bacquer D, et al Variation in Secondary Prevention of Coronary Heart Disease: The INTERASPIRE
Study.
Eur Heart J. 2024 Aug 30:ehae558. doi: 10.1093. PubMedAbstract available
TARDIF JC, Ouellette K, Boulet J Colchicine improves outcomes in coronary disease, but will it in heart failure?
Eur Heart J. 2024 Aug 30:ehae612. doi: 10.1093. PubMed
MAHAFFEY KW, Tuttle KR, Arici M, Baeres FMM, et al Cardiovascular outcomes with semaglutide by severity of chronic kidney disease in
type 2 diabetes: the FLOW trial.
Eur Heart J. 2024 Aug 30:ehae613. doi: 10.1093. PubMedAbstract available
CREA F Expanding knowledge in atrial fibrillation, blood pressure treatment, and
management of coronary and peripheral artery disease.
Eur Heart J. 2024;45:2795-2799. PubMed
PAVASINI R, Biscaglia S, Kunadian V, Hakeem A, et al Coronary artery disease management in older adults: revascularization and
exercise training.
Eur Heart J. 2024;45:2811-2823. PubMedAbstract available
CREA F Heart failure and ischaemic heart disease: new challenges and opportunities.
Eur Heart J. 2024;45:2681-2685. PubMed
BURZOTTA F, Zito A, Aurigemma C, Romagnoli E, et al Fractional flow reserve or optical coherence tomography for angiographically
intermediate coronary stenoses: 5-year outcomes in the FORZA trial.
Eur Heart J. 2024;45:2785-2788. PubMed
VOLLEBERG R, Damman P, van Royen N Dissection-like appearance of focal catheter-induced vasospasm in intracoronary
optical coherence tomography.
Eur Heart J. 2024;45:2793. PubMed
CIULLO A, Li L, Li C, Tsi K, et al Non-coding RNA yREX3 from human extracellular vesicles exerts macrophage-mediated
cardioprotection via a novel gene-methylating mechanism.
Eur Heart J. 2024;45:2660-2673. PubMedAbstract available
PEDICINO D, Vergallo R Weekly Journal Scan: Drug-coated balloon for the treatment of in-stent restenosis
- the AGENT IDE trial.
Eur Heart J. 2024;45:2592-2593. PubMed
July 2024
LIUZZO G, Patrono C Weekly Journal Scan: apolipoprotein A1 is not an adequate shield against early
vascular events after acute myocardial infarction.
Eur Heart J. 2024 Jul 26:ehae446. doi: 10.1093. PubMed
BESOLA L, Colli A, De Caterina R Coronary bypass surgery for multivessel disease after percutaneous coronary
intervention in acute coronary syndromes: why, for whom, how early?
Eur Heart J. 2024 Jul 26:ehae413. doi: 10.1093. PubMedAbstract available
KANG J, Yun J, Park KW, Park M, et al Long-term outcomes of high bleeding risk patients undergoing percutaneous
coronary intervention: a Korean nationwide registry.
Eur Heart J. 2024 Jul 23:ehae462. doi: 10.1093. PubMedAbstract available
CREA F Focus on acute myocardial infarction, sex-related differences in coronary bypass
surgery, inflammation in heart failure, and infective endocarditis in prosthetic
valves.
Eur Heart J. 2024;45:2463-2467. PubMed
GIANNITSIS E, Frey N, Katus HA Accelerated high sensitivity troponin diagnostics: ready for an even faster pace?
Eur Heart J. 2024;45:2516-2518. PubMed
DIEZ BENAVENTE E, Sakkers TR, van der Harst P, den Ruijter HM, et al Atherosclerotic plaque-specific methylation biomarkers in plasma cell-free DNA of
female and male patients with coronary artery disease.
Eur Heart J. 2024;45:2468-2470. PubMed
AHMAD Y, Lansky AJ Periprocedural myocardial infarction: thresholds of (in)significance.
Eur Heart J. 2024 Jul 19:ehae451. doi: 10.1093. PubMed
JURADO-ROMAN A, Agudo-Quilez P Tailoring antithrombotic treatment in patients with acute myocardial infarction
and cancer: virtue lies in balance.
Eur Heart J. 2024 Jul 19:ehae445. doi: 10.1093. PubMed
DAFAALLA M, Costa F, Kontopantelis E, Araya M, et al Bleeding risk prediction after acute myocardial infarction-integrating cancer
data: the updated PRECISE-DAPT cancer score.
Eur Heart J. 2024 Jul 17:ehae463. doi: 10.1093. PubMedAbstract available
FIGTREE GA, Gray MP Improving clinical outcomes for patients with coronary artery disease despite no
standard modifiable cardiovascular risk factors (SMuRF): not out of the woods
yet.
Eur Heart J. 2024;45:2407-2409. PubMed
ROGER G, Ducrocq G, Mesnier J, Sayah N, et al Chronic coronary syndromes without standard modifiable cardiovascular risk
factors and outcomes: the CLARIFY registry.
Eur Heart J. 2024;45:2396-2406. PubMedAbstract available
BEKKI M, Tahara N, Fukumoto Y Primary cardiac lymphoma causing coronary artery compression and massive
tricuspid regurgitation.
Eur Heart J. 2024 Jul 2:ehae390. doi: 10.1093. PubMed
June 2024
SCHELDEMAN L, Sinnaeve P, Albers GW, Lemmens R, et al Acute myocardial infarction and ischaemic stroke: differences and similarities in
reperfusion therapies-a review.
Eur Heart J. 2024 Jun 28:ehae371. doi: 10.1093. PubMedAbstract available
VILAHUR G, Radike M, Badimon L Novel cardioprotective approaches in ischaemic heart disease.
Eur Heart J. 2024;45:2109-2111. PubMed
HOLFELD J, Nagele F, Polzl L, Engler C, et al Cardiac shockwave therapy in addition to coronary bypass surgery improves
myocardial function in ischaemic heart failure: the CAST-HF trial.
Eur Heart J. 2024 Jun 20:ehae341. doi: 10.1093. PubMedAbstract available
SCHLOTTER F, Huber K, Hassager C, Halvorsen S, et al Ventricular septal defect complicating acute myocardial infarction: diagnosis and
management. A Clinical Consensus Statement of the Association for Acute
CardioVascular Care (ACVC) of the ESC, the European Association of Percutaneous
Cardiovascular In
Eur Heart J. 2024 Jun 18:ehae363. doi: 10.1093. PubMedAbstract available
PEDICINO D, Volpe M Weekly Journal Scan: do we need beta-blockers after myocardial infarction with
preserved ejection fraction?
Eur Heart J. 2024 Jun 14:ehae368. doi: 10.1093. PubMed
COUGHLAN JJ, Durand R, Byrne RA An initial invasive strategy in older patients with non-ST elevation acute
coronary syndromes: it is never too late.
Eur Heart J. 2024;45:2063-2065. PubMed
KOTANIDIS CP, Mills GB, Bendz B, Berg ES, et al Invasive vs. conservative management of older patients with non-ST-elevation
acute coronary syndrome: individual patient data meta-analysis.
Eur Heart J. 2024;45:2052-2062. PubMedAbstract available
BEERKENS FJ, Bhatt DL Non-ST-elevation acute coronary syndromes with previous coronary artery bypass
grafting: is a routine invasive strategy needed?
Eur Heart J. 2024 Jun 7:ehae287. doi: 10.1093. PubMed
CULLEN L, Greenslade J, Parsonage W, Stephensen L, et al Point-of-care high-sensitivity cardiac troponin in suspected acute myocardial
infarction assessed at baseline and 2 h.
Eur Heart J. 2024 Jun 6:ehae343. doi: 10.1093. PubMedAbstract available
LIUZZO G, Patrono C Weekly Journal Scan: sodium/glucose cotransporter 2 inhibition after myocardial
infarction still in the grey area.
Eur Heart J. 2024 Jun 1:ehae304. doi: 10.1093. PubMed
VERGALLO R, Pedicino D Weekly Journal Scan: Impella CP in myocardial infarction complicated by
cardiogenic shock.
Eur Heart J. 2024 Jun 1:ehae306. doi: 10.1093. PubMed
UZOKOV J, Alyavi A, Alyavi B, Abdullaev A, et al How artificial intelligence can assist with ischaemic heart disease.
Eur Heart J. 2024;45:1866-1868. PubMed
May 2024
REN J, Bowyer A, Tian DH, Royse C, et al Multiple arterial vs. single arterial coronary artery bypass grafting:
sex-related differences in outcomes.
Eur Heart J. 2024 May 31:ehae294. doi: 10.1093. PubMedAbstract available
KELHAM M, Vyas R, Ramaseshan R, Rathod K, et al Non-ST-elevation acute coronary syndromes with previous coronary artery bypass
grafting: a meta-analysis of invasive vs. conservative management.
Eur Heart J. 2024 May 28:ehae245. doi: 10.1093. PubMedAbstract available
KWON O, Ahn JH, Koh JS, Park Y, et al Platelet-fibrin clot strength and platelet reactivity predicting cardiovascular
events after percutaneous coronary interventions.
Eur Heart J. 2024 May 28:ehae296. doi: 10.1093. PubMedAbstract available
CREA F The growing role of coronary computed tomography angiography, polygenic risk
scores and electronic nudges in the management of ischaemic heart disease.
Eur Heart J. 2024;45:1769-1773. PubMed
NURMOHAMED NS, van Rosendael AR, Danad I, Ngo-Metzger Q, et al Atherosclerosis evaluation and cardiovascular risk estimation using coronary
computed tomography angiography.
Eur Heart J. 2024;45:1783-1800. PubMedAbstract available
HARIK L, Gaudino M Coronary angiography and bypass surgery: born together and now going separate
ways?
Eur Heart J. 2024;45:1816-1818. PubMed
SERRUYS PW, Kageyama S, Pompilio G, Andreini D, et al Coronary bypass surgery guided by computed tomography in a low-risk population.
Eur Heart J. 2024;45:1804-1815. PubMedAbstract available
LEE YJ, Shin S, Kwon SW, Suh Y, et al Ticagrelor monotherapy for acute coronary syndrome: an individual patient data
meta-analysis of TICO and T-PASS trials.
Eur Heart J. 2024 May 16:ehae249. doi: 10.1093. PubMedAbstract available
DVIR D, Tchetche D, Leon MB, Genereux P, et al Leaflet modification before transcatheter aortic valve implantation in patients
at risk for coronary obstruction: the ShortCut study.
Eur Heart J. 2024 May 15:ehae303. doi: 10.1093. PubMedAbstract available
PAOLUCCI L, Mangiacapra F, Sergio S, Nusca A, et al Periprocedural myocardial infarction after percutaneous coronary intervention and
long-term mortality: a meta-analysis.
Eur Heart J. 2024 May 14:ehae266. doi: 10.1093. PubMedAbstract available
CREA F Focus on ischaemic heart disease: prevention with colchicine, role of the
brain-heart axis, new therapeutic targets for ischaemia-reperfusion injury.
Eur Heart J. 2024;45:1577-1581. PubMed
TAKAHARA M, Soga Y, Iida O Lower extremity arterial disease vs. coronary artery disease: mortality
differences after revascularization.
Eur Heart J. 2024;45:1634-1643. PubMedAbstract available
AMPONSAH-OFFEH M, Tual-Chalot S, Stellos K Repurposing of an antiasthmatic drug may reduce NETosis and myocardial
ischaemia/reperfusion injury.
Eur Heart J. 2024;45:1681-1683. PubMed
YANG K, Gao R, Chen H, Hu J, et al Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by
neutrophil extracellular traps and prevented by leukotriene C4 inhibition.
Eur Heart J. 2024;45:1662-1680. PubMedAbstract available
ADLAM D, van Dijk FS, Loeys B Genetic testing in patients with unexplained coronary aneurysms or dilation.
Eur Heart J. 2024;45:1610-1612. PubMed
JONES DA, Beirne AM, Kelham M, Wynne L, et al Inorganic nitrate benefits contrast-induced nephropathy after coronary
angiography for acute coronary syndromes: the NITRATE-CIN trial.
Eur Heart J. 2024;45:1647-1658. PubMedAbstract available
XIAO Q, Xu Y, Wang S Gastropericardial fistula complicated by severe multi-vessel coronary spasm.
Eur Heart J. 2024;45:1685. PubMed
CHEN Z, Dazard JE, Khalifa Y, Motairek I, et al Artificial intelligence-based assessment of built environment from Google Street
View and coronary artery disease prevalence.
Eur Heart J. 2024;45:1540-1549. PubMedAbstract available
HEUSCH G, Kleinbongard P Cardioprotection research has left its comfort zone.
Eur Heart J. 2024;45:1568-1570. PubMed
VERGALLO R, Patrono C Weekly journal scan: intravascular imaging to guide percutaneous coronary
intervention-ready for prime time?
Eur Heart J. 2024 May 4:ehae242. doi: 10.1093. PubMed
April 2024
NGO LTH, Peng Y, Denman R, Yang I, et al Long-term outcomes after hospitalization for atrial fibrillation or flutter.
Eur Heart J. 2024 Apr 28:ehae204. doi: 10.1093. PubMedAbstract available
GALIUTO L, Volpe M Weekly journal scan: excess incidence of unexpected health outcomes following
myocardial infarction-broader paths for secondary prevention.
Eur Heart J. 2024 Apr 15:ehae229. doi: 10.1093. PubMed
BHATT AS, Johansen ND, Modin D, Claggett BL, et al Electronic nudges increase influenza vaccination utilization after myocardial
infarction: the nationwide NUDGE-FLU implementation trial.
Eur Heart J. 2024 Apr 10:ehae235. doi: 10.1093. PubMed
VERGALLO R, Galiuto L Weekly journal scan: angina severity reduced by percutaneous coronary
intervention in the ORBITA-2 trial.
Eur Heart J. 2024 Apr 10:ehae215. doi: 10.1093. PubMed
CREA F The complex interaction between cancer, ischaemic heart disease, and heart
failure, and a focus on arrhythmias including risk stratification in Brugada
syndrome and leadless pacing.
Eur Heart J. 2024;45:1183-1187. PubMed
KASKI JC, Al-Lamee R, Boden WE The year in cardiovascular medicine 2023: the top 10 papers in ischaemic heart
disease.
Eur Heart J. 2024;45:1201-1204. PubMed
AMERI P, Bertero E, Lombardi M, Porto I, et al Ischaemic heart disease in patients with cancer.
Eur Heart J. 2024;45:1209-1223. PubMedAbstract available
BYRNE R, Coughlan JJ, Rossello X, Ibanez B, et al The '10 commandments' for the 2023 ESC Guidelines for the management of acute
coronary syndromes.
Eur Heart J. 2024;45:1193-1195. PubMed
CALLEGARI A, Bonnet D, Malekzadeh-Milani S Successful percutaneous treatment of perinatal complete left coronary thrombotic
occlusion.
Eur Heart J. 2024;45:1285. PubMed
WU VC, Yeh JK, Chen SW, Wu CL, et al Syphilis and cardiovascular risk: a Taiwanese registry.
Eur Heart J. 2024 Apr 3:ehae183. doi: 10.1093. PubMedAbstract available
SAYAH N, Bhatt DL, Miller M, Brinton EA, et al Icosapent ethyl following acute coronary syndrome: the REDUCE-IT trial.
Eur Heart J. 2024;45:1173-1176. PubMed
March 2024
LI L, Pang S, Starnecker F, Mueller-Myhsok B, et al Integration of a polygenic score into guideline-recommended prediction of
cardiovascular disease.
Eur Heart J. 2024 Mar 29:ehae048. doi: 10.1093. PubMedAbstract available
WYLD M, Webster AC Myocardial infarction and stroke in patients with kidney failure: can we do
better?
Eur Heart J. 2024 Mar 27:ehae153. doi: 10.1093. PubMed
TSUDA K, Nagamatsu W, Morii I A collateral channel from the bronchial artery in chronic total occlusion of
proximal right coronary artery.
Eur Heart J. 2024;45:1087. PubMed
VILAHUR G, Radike M, Sutelman P, Ben-Aicha S, et al Recombinant human soluble domain of CD39L3 and ticagrelor: cardioprotective
effects in experimental myocardial infarction.
Eur Heart J. 2024 Mar 15:ehae107. doi: 10.1093. PubMedAbstract available
URSO S, Sadaba R, Dayan V Benefits of coronary artery bypass grafting over percutaneous coronary
intervention in left main disease: the strength of the evidence.
Eur Heart J. 2024 Mar 5:ehae135. doi: 10.1093. PubMed
VERGALLO R, Galiuto L Weekly journal scan: do biodegradable polymer stents provide a durable benefit in
patients with ST-segment elevation myocardial infarction?
Eur Heart J. 2024 Mar 4:ehae119. doi: 10.1093. PubMed
GALLACHER PJ, Yeung D, Bell S, Shah ASV, et al Kidney replacement therapy: trends in incidence, treatment, and outcomes of
myocardial infarction and stroke in a nationwide Scottish study.
Eur Heart J. 2024 Mar 1:ehae080. doi: 10.1093. PubMedAbstract available
CREA F Ischaemic heart disease: prevention, management, mechanisms, and new therapeutic
targets.
Eur Heart J. 2024;45:637-641. PubMed
JANSEN TPJ, Wentzel JJ, Damman P Interplay between coronary bridging and high shear stress in the emergence of
coronary vasospasm.
Eur Heart J. 2024;45:737. PubMed
February 2024
CHEONG HS, Chang Y, Kim Y, Kwon MJ, et al Human papillomavirus infection and cardiovascular mortality: a cohort study.
Eur Heart J. 2024 Feb 7:ehae020. doi: 10.1093. PubMedAbstract available
THYREGOD HGH, Jorgensen TH, Ihlemann N, Steinbruchel DA, et al Transcatheter or surgical aortic valve implantation: 10-year outcomes of the
NOTION trial.
Eur Heart J. 2024 Feb 7:ehae043. doi: 10.1093. PubMedAbstract available
January 2024
SENIOR R, Khattar RS To test or not to test for ischaemia routinely after percutaneous coronary
intervention in diabetic patients: is the jury still out?
Eur Heart J. 2024 Jan 30:ehad877. doi: 10.1093. PubMed
PERSITS I, Layoun H, Kondoleon NP, Spilias N, et al Impact of untreated chronic obstructive coronary artery disease on outcomes after
transcatheter aortic valve replacement.
Eur Heart J. 2024 Jan 25:ehae019. doi: 10.1093. PubMedAbstract available
GOBEIL E, Bourgault J, Mitchell PL, Houessou U, et al Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic
risk.
Eur Heart J. 2024 Jan 19:ehad845. doi: 10.1093. PubMedAbstract available
LI Z, Zhang H, Lin S Functionally bicuspid aortic valve leads to myocardial ischaemia.
Eur Heart J. 2024 Jan 18:ehad891. doi: 10.1093. PubMed
December 2023
PIRIOU PG, Plessis J, Guerin P Transcatheter aortic valve replacement in patients with cardiogenic shock: safe
and effective, but the most critical patients require further investigations.
Eur Heart J. 2023 Dec 14:ehad808. doi: 10.1093. PubMed
November 2023
LU ZN, Yang Y, Song G A patient-tailored clipping strategy of transcatheter edge-to-edge repair as
salvage for cardiogenic shock complicated by mitral valve cleft and bileaflet
flails.
Eur Heart J. 2023 Nov 29:ehad802. doi: 10.1093. PubMed
HENRY CM, Oseran AS, Zheng Z, Dong H, et al Cardiovascular Hospitalizations and Mortality Among Adults Aged 25 to 64 years in
the United States.
Eur Heart J. 2023 Nov 11:ehad772. doi: 10.1093. PubMedAbstract available
KIM H, Kang DY, Lee J, Choi Y, et al Routine stress testing in diabetic patients after percutaneous coronary
intervention: the POST-PCI trial.
Eur Heart J. 2023 Nov 2:ehad722. doi: 10.1093. PubMedAbstract available